An Open-label, Multicenter, Single-arm, Phase 4 Study of the Effect of Treatment with Velaglucerase alfa on Bone-related Pathology in Treatment-naive Patients with Type 1 Gaucher Disease

Administered By

Awarded By

Contributors

Start/End

  • December 12, 2016 - January 31, 2022